GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA Tags Diabetic ketoacidosis Hypoglycemia GLP-1 agonists Read more about GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA
AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD Tags Coronary artery disease GLP-1 agonists Read more about AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD
AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin
AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM Tags Hyperglycemia hyperosmolar state Long acting Read more about AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM
AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM Tags GLP-1 agonists PLBS hBA1c Read more about AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM
Early AID Adoption in New-Onset T1DM Shows Low Hypoglycemia Burden Tags Diabetic ketoacidosis Hypoglycemia Insulin Pumps Others Delivery devices Continuous glucose monitoring (CGM) Read more about Early AID Adoption in New-Onset T1DM Shows Low Hypoglycemia Burden
AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin
AACE 2026: Inpatient Glycemia Improves With Insulin Pump Continuation Tags Hypoglycemia Insulin Pumps Read more about AACE 2026: Inpatient Glycemia Improves With Insulin Pump Continuation
Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy Tags SGLT-2 Inhibitor Read more about Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy
AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss Tags hBA1c GLP-1 agonists Read more about AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss